KATRINA MYLETT: Open Payments
NPI 1992168355 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 41 payments from 11 companies in 2025. Trend: 2023 $1,279 · 2024 $840 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $146 |
| Exact Sciences Corporation | 4 | $119 |
| Novo Nordisk Inc | 5 | $101 |
| ABBVIE INC. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Lilly USA, LLC | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
Products named: The Cologuard Plus Collection Kit, OTEZLA, CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, BREZTRI, MOUNJARO, Ozempic.
Industry payments across FL — which companies pay providers there.
